Pegalan, Fred Vincent F.
HRN: 01-55-50 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/27/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/27/2023
06/03/2023
IV
500mg
Q8H
ASA, GSW
Checking Final Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes